Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
18.7M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$11.2M
-
Value change
-
+$698K
-
Put/Call ratio
-
0
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$0.60
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q4 2024
31 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q4 2024.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.7M shares
of 104M outstanding shares and own 18.04% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (8.48M shares), Lagoda Investment Management, L.P. (7.58M shares), GEODE CAPITAL MANAGEMENT, LLC (744K shares), VANGUARD GROUP INC (637K shares), BlackRock, Inc. (445K shares), STATE STREET CORP (148K shares), Silverberg Bernstein Capital Management LLC (134K shares), NORTHERN TRUST CORP (118K shares), UBS Group AG (107K shares), and CITADEL ADVISORS LLC (68.2K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.